Paris, June 15 (RHC-PL)-- Dulce Buergo, Cuba's ambassador to UNESCO, speaking at the 29th meeting of the International Coordination Council, ratified her country's commitment to the Man and the Biosphere Program (MAB).
At the meeting, the diplomatic representative highlighted the intense action of the MAB National Committee, in the coordination of the six Biosphere reserves in Cuba.
She also commented on the numerous initiatives undertaken to strengthen the work of protecting the reserves and their active participation in the different activities called for by the Ibero-American MAB Network.
The ambassador made particular reference to the upcoming 11th Convention on Environment and Development, scheduled in Havana in July, during which, in coordination with the MAB Committee, the 10th International Congress of Protected Areas will also be held.
According to Buergo, 'the main objective of the event is to promote the exchange of knowledge and experiences in relation to the management and planning of national systems of protected areas, their natural and historical-cultural resources, linked to social, economic, and financial sustainability.'
The 29th meeting of the MAB International Coordination Council began Monday at the Paris headquarters of UNESCO and will run until tomorrow with an extensive program of activities.
Cuba Ratifies Commitment to UNESCO's Man and the Biosphere Program

Articles en relation
Commentaires
Laissez un commentaire
Tous les champs sont requis
En reproduction maintenant
En Contacto
Au suivant
- En Compañía del Doctor
- Noticiero
- El Mundo de la Filatelia
Plus de visites
- Le ministre cubain des Affaires étrangères condamne l'usage de la force contre les manifestants aux États-Unis
- Cuba condamne le massacre et la mutilation de Palestiniens dans un centre de distribution d'aide à Gaza
- Les États-Unis et Israël seront tenus responsables des conséquences d'une guerre non justifiée contre l'Iran
- Cuba remercie Lula da Silva pour son soutien contre le blocus et la désignation comme sponsor du terrorisme (+Post)
- L'essai clinique de phase III du médicament Jusvinza pour le traitement de la polyarthrite rhumatoïde avance